NCT01114984

Brief Summary

The purpose of this study is to better understand and characterize the pain that some patients experience after undergoing various breast surgeries, including breast biopsy, lumpectomy, mastectomy, mastectomy with reconstruction, cosmetic breast augmentation, and breast reduction.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 23, 2010

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 3, 2010

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

March 2, 2015

Status Verified

February 1, 2015

Enrollment Period

4.9 years

First QC Date

April 23, 2010

Last Update Submit

February 26, 2015

Conditions

Keywords

Pain managementRadical mastectomyBreast surgerypost-operative pain

Outcome Measures

Primary Outcomes (1)

  • Postoperative Pain using VRS

    prospective cohort evaluation of patients undergoing various breast surgery procedures, followed for a period of 6 months post-operatively, and assessed for post-operative breast pain.

    6 months

Secondary Outcomes (5)

  • Opioid consumption obtained from the recorded data

    6 months

  • Postoperative nausea and vomiting using a Verbal Rating Scale

    6 months

  • Return to normal activities of daily living using follow up questionnaires

    6 months

  • Patient satisfaction using a verbal rating scale from 0 to 100

    6 months

  • Hospital stay

    up to 1 week

Study Arms (8)

10% after breast biopsy

Incidence Post-operative pain after breast surgery.

20% after lumpectomy

Incidence Post-operative pain after breast surgery

30% after simple mastectomy

Incidence Post-operative pain after breast surgery

50% after mastectomy with reconstruction

Incidence Post-operative pain after breast surgery

50% after radical mastectomy

Incidence Post-operative pain after breast surgery

50% after radi mastectomy+reconstruction

Incidence Post-operative pain after breast surgery after radical mastectomy with reconstruction

40% after cosmetic augmentation

Incidence Post-operative pain after breast surgery

40% after breast reduction

Incidence Post-operative pain after breast surgery

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergo breast surgery. (breast biopsy, lumpectomy, simple mastectomy,mastectomy with reconstruction, radical mastectomy, radical mastectomy with reconstruction, cosmetic augmentation and breast reduction)

You may qualify if:

  • Patients scheduled to undergo one or more of the breast surgical procedures being studied for this project
  • Willingness and ability to sign an informed consent document
  • No allergies to anesthetic or analgesic medications
  • Female,
  • years of age
  • ASA class I-III adult

You may not qualify if:

  • Patients with known allergy, hypersensitivity or contraindications to anesthetic or analgesic medications
  • Patients with clinically-significant medical conditions, such as brain, heart, kidney, endocrine, or liver diseases, or history of chronic pain syndrome or neuropathy.
  • Subjects with a history of alcohol or drug abuse within the past 3 months
  • Subjects with a history of pain medication abuse
  • Any other conditions or use of any medication which may interfere with the conduct of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cedars Sinai Medical Center

Los Angeles, California, 90048, United States

Location

MeSH Terms

Conditions

AgnosiaPain, Postoperative

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPain

Study Officials

  • Roya Yumul, MD, PhD

    Cedars-Sinai Medical Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Residency program director, Department of anesthesiology

Study Record Dates

First Submitted

April 23, 2010

First Posted

May 3, 2010

Study Start

July 1, 2009

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

March 2, 2015

Record last verified: 2015-02

Locations